Alzheimer's disease (AD) stands as the predominant form of dementia, presenting significant
and escalating global challenges. Its etiology is intricate and diverse, stemming from a …

Synaptic mitochondria are crucial for maintaining synaptic activity due to their high energy
requirements, substantial calcium (Ca 2+) fluctuation, and neurotransmitter release at the …

GluN2B-induced activation of NMDA receptors plays a key function in central nervous
system (CNS) disorders, including Parkinson, Alzheimer, and stroke, as it is strongly …

Alzheimer's disease (AD) is a progressive neurodegenerative disease for which there is a
lack of effective therapeutic drugs. There is great potential for natural products to be used in …

Alzheimer's disease (AD) is an age-related progressive neurodegenerative disorder that
leads to cognitive impairment and memory loss. Emerging evidence suggests that …

Alzheimer's Disease (AD) is a global public health priority characterized by high mortality
rates in adults and an increasing prevalence in aging populations worldwide. Despite …

At present, one of the most promising strategies to tackle the complex challenges posed by
Alzheimer's disease (AD) involves the development of novel multitarget-directed ligands …

Optimizing extraction conditions can help maximize the efficiency and yield of the extraction
process while minimizing negative impacts on the environment and human health. For the …

Alzheimer's disease (AD, also known as dementia) has become a serious global health
problem along with population aging, and neuroinflammation is the underlying cause of …

Gamma-glutamate is an important excitatory neurotransmitter in the central nervous system
(CNS), which plays an important role in transmitting synapses, plasticity, and other brain …